The role of vitamin E and C therapy in NASH [2]

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1862-

  Harrison, Stephen A ^a   Ward, John A ^a   Schenker, Steven ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID;

ANTIOXIDANT ACTIVITY; DATA ANALYSIS; HUMAN; LETTER; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANTIOXIDANTS; ASCORBIC ACID; BIOPSY, NEEDLE; DIETARY SUPPLEMENTS; FATTY LIVER; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; PROBABILITY; RANDOMIZED CONTROLLED TRIALS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VITAMIN E;

EID: 19344373201     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40539_3.x     Document Type: Letter

References (3)

1. Adams LA, Angulo P. Vitamin E and C for the treatment of NASH: Duplication of results but lack of demonstration of efficacy. Am J Gastroenterol 2003;98:2348 (editorial).
2. Harrison SA, Torgerson S, Hayashi P, et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003;98:2485.
3. Harrison SA, Kadakia S, Lang KA, et al. Nonalcoholic steatohepatitis: What we know in the new millennium. Am J Gastroenterol 2002;97:2714-24.